May 12, 2008, 23:41 | 0 (0 Votes) | 0 Comments
AstraZeneca's Toprol Raises Risk of Death, Stroke, Study Says
... beta-blocker regimen has benefit without substantial harm,'' authors led by researcher PJ Devereaux from McMaster University in Hamilton, Ontario wrote. ...
Please log in to rate this.

Comments (0)
No one has posted any comments yet. Perhaps you'd like to be the first?

Please log in to add comment.